NK Dendritic Cells Expanded in IL-15 Exhibit Antitumor Responses In Vivo
Author(s) -
Umer I. Chaudhry,
George Plitas,
Bryan M. Burt,
T. Peter Kingham,
Jesse R. Raab,
Ronald P. DeMatteo
Publication year - 2007
Publication title -
the journal of immunology
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.179.7.4654
Subject(s) - interleukin 12 , cytolysis , microbiology and biotechnology , biology , cytokine , interleukin 15 , in vivo , dendritic cell , immunology , interleukin 21 , in vitro , t cell , cancer research , chemistry , interleukin , immune system , cytotoxic t cell , biochemistry
NK dendritic cells (NKDC) are a novel subtype of DC with NK cell properties. IL-15 is a pleiotropic cytokine that plays an obligate role in the proliferation and survival of NK cells. We hypothesized that IL-15 is also essential for NKDC development. NKDC were nearly absent in IL-15(-/-) mice, but restored by administration of exogenous IL-15. Treatment of wild-type mice with IL-15 caused a 2- to 3-fold expansion of both NK cells and NKDC. After 7 days of culture with IL-15, sorted splenic NKDC expanded 10-fold while NK cells increased 5-fold. NKDC expanded in IL-15 retained their cytolytic capacity but lost the ability to stimulate naive T cells. Meanwhile, NKDC expanded in IL-15 produced 10 times more IFN-gamma as fresh NKDC and conferred protection in a tumor prevention model. Thus, IL-15 is essential to the proliferation and survival of NKDC and IL-15 expanded NKDC possess antitumor properties.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom